HALOZYME THERAPEUTICS, INC. — Cash Flow Charts
2 years of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow
$652M
Free Cash Flow
$645M
Investing Cash Flow
$-546M
Financing Cash Flow
$-85M
Capex
$7M
Acquisitions
$726M
Stock Buybacks
$342M
Stock-Based Comp
$52M
Debt Repaid
—
D&A
$11M
SBC Allocated Expense
$52M